[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Monday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=6e6a79a3b9de63d7c9f630ae6c1a31c52bd56b7300a15321a2fce6f7f062cd6a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748882160,
      "headline": "Gilead Sciences Inc. stock underperforms Monday when compared to competitors",
      "id": 134985246,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=6e6a79a3b9de63d7c9f630ae6c1a31c52bd56b7300a15321a2fce6f7f062cd6a"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Reports Positive Data From Trodelvy, Keytruda Combo Study",
    "summary": "GILD posts strong phase III results for Trodelvy plus Keytruda, cutting TNBC progression risk by 35% compared with standard care.",
    "url": "https://finnhub.io/api/news?id=7ec6c60c9bf14a5ee9be480d47c6aa9e4d093b6489b15707098fb0e5ce547a98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748871480,
      "headline": "Gilead Reports Positive Data From Trodelvy, Keytruda Combo Study",
      "id": 134947502,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "GILD posts strong phase III results for Trodelvy plus Keytruda, cutting TNBC progression risk by 35% compared with standard care.",
      "url": "https://finnhub.io/api/news?id=7ec6c60c9bf14a5ee9be480d47c6aa9e4d093b6489b15707098fb0e5ce547a98"
    }
  },
  {
    "ts": null,
    "headline": "Put Cash To Work: 2 Magnificent Dividends I'm Betting On",
    "summary": "Discover why RTX & AbbVie are top picks for growth & income.",
    "url": "https://finnhub.io/api/news?id=055adbcc07b3c97a6108e18da5df5139ba8c3f57b9c90f63dc0ab0c36819f5d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748858400,
      "headline": "Put Cash To Work: 2 Magnificent Dividends I'm Betting On",
      "id": 134939270,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126636461/image_1126636461.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Discover why RTX & AbbVie are top picks for growth & income.",
      "url": "https://finnhub.io/api/news?id=055adbcc07b3c97a6108e18da5df5139ba8c3f57b9c90f63dc0ab0c36819f5d2"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences : EFPIA Methodological Note 2024 (gilead sciences efpia methodological note 2024)",
    "summary": "Methodological Note Contents Introduction 2 Definition of Transfers of Value 2 ...",
    "url": "https://finnhub.io/api/news?id=b17155c2220ec0fa44dccb012e2eaf63308cd9b970cb8e547a5e2d4f991cb4b2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748846705,
      "headline": "Gilead Sciences : EFPIA Methodological Note 2024 (gilead sciences efpia methodological note 2024)",
      "id": 134935895,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Methodological Note Contents Introduction 2 Definition of Transfers of Value 2 ...",
      "url": "https://finnhub.io/api/news?id=b17155c2220ec0fa44dccb012e2eaf63308cd9b970cb8e547a5e2d4f991cb4b2"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences : 2025 EFPIA Disclosure code – Self-Certification letter (gilead 2025 disclosure code self certification letter)",
    "summary": "EFPIA Code Disclosure 2025 Self-Certification Scheme Healthcare professionals and healthcare organisations with whom Gilead Sciences works provide the pharmaceutical industry...",
    "url": "https://finnhub.io/api/news?id=4609db317618d2561d5088e7868c82029ff164c733db961829ef8a97e1828f1d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748846705,
      "headline": "Gilead Sciences : 2025 EFPIA Disclosure code – Self-Certification letter (gilead 2025 disclosure code self certification letter)",
      "id": 134935894,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "EFPIA Code Disclosure 2025 Self-Certification Scheme Healthcare professionals and healthcare organisations with whom Gilead Sciences works provide the pharmaceutical industry...",
      "url": "https://finnhub.io/api/news?id=4609db317618d2561d5088e7868c82029ff164c733db961829ef8a97e1828f1d"
    }
  }
]